Good morning. What happens to an organization after it achieves a moonshot? That has been Albert Bourla’s reality, post-COVID. As the CEO of Pfizer, a company he first joined in 1993, Bourla—a ...

Pfizer, by contrast, appears diversified but diffuse—its pipeline may contain value, but that value is not yet organized into ...

Pfizer (NYSE:PFE) used its 2026 annual meeting of shareholders to highlight recent operational performance, outline strategic ...

SAN FRANCISCO, Jan 12 (Reuters) - Pfizer is preparing for ‌a consumer market for obesity drugs on ‌par with the booming business it saw after it launched erectile dysfunction drug Viagra in 1998, CEO ...

During an appearance on CBS News Sunday, Pfizer CEO Albert Bourla said that Americans would need a fourth dose of a COVID-19 vaccine to fend off future variants of the virus. Speaking with anchor ...

As the CEO of Pfizer, Albert Bourla led the team behind one of the most consequential medical breakthroughs of the modern era: the COVID-19 vaccine that saved millions of lives. Yet the leadership ...

Pfizer (PFE) stock is in focus as executive Andrew Baum, who joined the company in 2024 as the Chief Strategy and Innovation ...

Pfizer’s chief strategist, Andrew Baum, M.D., is leaving his post two years after pivoting from a career-long tenure as a ...

"We are not going back to before Louis Pasteur times,” declared Pfizer CEO Andrew Bourla on a Tuesday morning analyst call, saying the pharma giant will continue its “long-term investment” in vaccines ...